Hospital pharmacists Chief Pharmacists to forward on to Medicines Information Pharmacists Community pharmacists

Similar documents
abcde abc a = eé~äíü=aéé~êíãéåí= = aáêéåíçê~íé=çñ=méêñçêã~ååé=j~å~öéãéåí== ~åç=cáå~ååé= ISBN NHS HDL(2003)31 abcdefghijklm

The NHS Chronic Medication Service at your local pharmacy

Charges from 1 st April 2010

GLUTEN- FREE FOOD SCHEME

Travel advice for people with cystic fibrosis

The Future of Air Transport

EASA Safety Information Notice

Revalidation: initial consultation

The Airport Charges Regulations 2011

OVERSEAS TERRITORIES AVIATION REQUIREMENTS (OTARs)

Information Governance

Revalidation: Recommendations from the Task and Finish Group

SMALL COMMERICIAL VESSEL CODE BAILIWICK OF GUERNSEY (SCV (BoG) CODE) CONSULTATION FEEDBACK SUMMARY

Travel medicines. Patient Information: Medicines. NHS Logo here. Working together for better patient information

Guernsey Travel Survey

North West London Hospitals NHS Trust

[Docket No. FAA ; Product Identifier 2017-NM-164-AD; Amendment ; AD ]

Airworthiness Directive

STRIVING FOR CONTINUING COMPETENCE

City of Danville Alcoholic Beverage Control

[Docket No. FAA ; Product Identifier 2017-NM-032-AD; Amendment ; AD ]

Council of the European Union Brussels, 27 March 2018 (OR. en)

Guernsey Travel Survey

IRELAND SAFETY REGULATION DIVISION IRISH AVIATION AUTHORITY AVIATION HOUSE HAWKINS STREET DUBLIN 2 Tel Fax AFTN EIDWYOYX

The GMC protocol for making revalidation recommendations: Guidance for responsible officers and suitable persons Fifth edition (March 2018)

BAE SYSTEMS (OPERATIONS) LIMITED

SUPERSEDED. [Docket No. FAA ; Directorate Identifier 2006-NM-205-AD; Amendment ; AD ]

Disclosure of Transfers of Value to Health Care Professionals. Stirling Anglian Pharmaceuticals Limited. Methodological Note 2015

Advice for brokers about the ATOL Regulations and the ATOL scheme

Insight Department: Scotland The key facts on tourism in 2016

Standard Operating Procedures: Individual Funding Requests

Declaration of Interests for the Financial Year 2012/13. Office

UKPHR Revalidation. Frequently Asked Questions for Registrants

Glider Airworthiness. CofA, ARC, CAMO, ADs and other codes!

Tour operator: Return flight: Flight number: from / to: Date: Booking class: Economy Premium Business

Aviation Regulation Latest Developments and Their Impact for Industry

[Docket No. FAA ; Product Identifier 2016-SW-077-AD] Airworthiness Directives; Scotts-Bell 47 Inc. (Type Certificate Previously Held by

Insight Department: Scotland The key facts on tourism in 2016

Seychelles Civil Aviation Authority SAFETY DIRECTIVE. Validation of Non-Seychelles licenses issued by States other than the Seychelles

7696/12 GL/mkl 1 DG C I C

SUPERSEDED. [Docket No. FAA ; Directorate Identifier 2008-NM-061-AD; Amendment ; AD ]

[Docket No. FAA ; Product Identifier 2017-CE-022-AD] AGENCY: Federal Aviation Administration (FAA), Department of Transportation

Travel Information for Adults with Sickle Cell Disease

Airworthiness Directive

Travelling with a chronic health condition/disability

NHS quango flights. Alex Wild April 2018

The Economic Impact of Tourism on Calderdale Prepared by: Tourism South East Research Unit 40 Chamberlayne Road Eastleigh Hampshire SO50 5JH

Update on implementation of Taking Revalidation Forward recommendations

Form SR FCL1175 Issue 1 (Nov 2007) Page 1 of 5

Airworthiness Directive

Information about your Nuclear Medicine Test

[Docket No. FAA ; Directorate Identifier 2004-NM-252-AD; Amendment ; AD ]

The Economic Impact of Tourism on Scarborough District 2014

Operations Specifications

[Docket No. FAA ; Product Identifier 2017-NM-141-AD; Amendment ; AD ]

Economic Impact of Tourism. Cambridgeshire 2010 Results

Approval of Dangerous Goods Training Programs Checklist Part I Part I Approval of Dangerous Goods Training Programs Checklist

Key purpose Strategy Assurance Policy Performance

THE CESSNA AIRCRAFT COMPANY

The Economic Impact of Tourism on the District of Thanet 2011

CAA Passenger Survey Report 2017

[Docket No. FAA ; Product Identifier 2018-CE-006-AD; Amendment. AGENCY: Federal Aviation Administration (FAA), Department of Transportation

[Docket No. FAA ; Product Identifier 2017-SW-004-AD] Airworthiness Directives; Airbus Helicopters Deutschland GmbH (Type Certificate

AUTUMN Lancaster October

Emergency Airworthiness Directive

[Docket No NE-47-AD; Amendment ; AD ]

Order. March 2013 ISSUE,RENEWALORRE-ISSUE OF A MEDICAL CERTIFICATE 1.0 PURPOSE 2.0 REFERENCES

[Docket No. FAA ; Directorate Identifier 2016-NM-133-AD; Amendment ; AD ]

Heyinovo. Disposable Biopsy Valves User Manual. Technical Publications. Document No: WI-RD-13-M07, Rev. B

[Docket No. FAA ; Product Identifier 2018-NM-097-AD; Amendment ; AD ]

IRELAND SAFETY REGULATION DIVISION

Team Members Information Pack (The practicalities of being on team)

Storage Pots for Tissue Grafts

1.2 Some of the figures included in this publication may be provisional and revised in later issues.

Overall Statistics for Scotland as at 14 May 2002 Consultants

Revalidation: data from the first five years

Amendment Docket No. FAA ; Directorate Identifier 2008-NM-220-AD

Advisory Circular. Aircraft Certification Authority Based on Foreign Qualifications

opyright East Riding of Yorkshire Cou

[Docket No. FAA ; Directorate Identifier 2015-SW-020-AD; Amendment. Airworthiness Directives; Sikorsky Aircraft Corporation Helicopters (Type

[Docket No. FAA ; Directorate Identifier 2015-SW-020-AD; Amendment ; AD ]

Aeromedical Examiner & Aeromedical Ophthalmologist Approvals

National Packaging Covenant Annual Report 2007/2008 PUBLIC DOCUMENT

[Docket No. FAA ; Product Identifier 2018-NE-19-AD; Amendment ; AD ]

SECTION B AIRWORTHINESS CERTIFICATION

Press Release 23/05/11

[Docket No. FAA ; Directorate Identifier 2013-NM-220-AD; Amendment ; AD ]

[Docket No. FAA ; Product Identifier 2018-NE-35-AD; Amendment ; AD ]

LONDON HIGHER FACTSHEET 2011

Power Stations. Emergency information for local residents

AIRWORTHINESS DIRECTIVE

SUPERSEDED. [Docket No. FAA ; Directorate Identifier 2015-SW-014-AD; Amendment ; AD ]

Traffic Calming Special Authorisations

Third Summit Meeting Jersey 14 th June 2002

Quarterly Statistics for New Businesses

International Civil Aviation Organization REVIEW OF STATE CONTINGENCY PLANNING REQUIREMENTS. (Presented by the Secretariat) SUMMARY

Combined CAME & MOE INITIAL / AMENDMENT* COMPLIANCE CHECK LIST

PEMBROKESHIRE & CORNWALL VISITOR SURVEYS 2011/12 COMPARING THE DESTINATIONS. February 2013

[Docket No. FAA ; Product Identifier 2018-NM-056-AD; Amendment ; AD ]

BGA GMP Sailplane and Self Sustaining Sailplane Maintenance Programme

Transcription:

Primary and Community Care Directorate Pharmacy Division T: 0131-244 2528 F: 0131-244 2375 E: irene.fazakerley@scotland.gsi.gov.uk 18 August 2009 abcdefghijklmnopqrstu = IMMEDIATE MESSAGE TO: 1. Directors of Pharmacy 2. Chief Pharmacists, NHS Boards 3. Hospital Pharmacy Managers 4. Medical Directors NHS Boards 5. Chief Executives NHS Boards Dear Healthcare Professional, DRUG ALERTS NO 23 CLASS 2 Please find attached revised drug safety information from the Medicines and Healthcare Products Regulatory Agency (MHRA) for onward transmission (see list below). 1. Please could Directors of Pharmacy forward this alert to:- Hospital pharmacists Chief Pharmacists to forward on to Medicines Information Pharmacists Community pharmacists 2. Please could Medical Directors forward the message on to :- General Practitoners Dispensing Doctors Chief Executives NHS Boards Thank you for your co-operation. Yours sincerely IRENE FAZAKERLEY Pharmacy Division * NB: Drug alerts have the following classifications: 1. Action now (including out-of-hours); 2. Action within 48 hours; 3. Action within 5 days; 4 Caution in use St Andrew s House, Regent Road, Edinburgh EH1 3DG www.scotland.gov.uk abcde abc a

Defective Medicines Report Centre Market Towers 1 Nine Elms Lane London SW8 5NQ Telephone: +44 (0)20 7084 2574 Fax: +44 (0)20 7084 2676 D R U G A L E R T CLASS 2 MEDICINES RECALL Action Within 48 Hours PHARMACY AND WHOLESALER LEVEL RECALL Date: 18 August 2009 EL (09)A/23 Our Ref: MDR 84-07/09 Dear Healthcare Professional, Karib Kemi Pharm Ltd Please note - Ciprofloxacin tablets are in both Karib Kemi Pharm and Sandoz Liveries. All other products are solely in Karib Kemi Pharm Livery Multiple Product Drug Alert Product Name PL No. Amoxicillin Caps 250mg 18224/0004 Amoxicillin Caps 500mg 18224/0005 Atenolol Tabs 50mg 18224/0018 Atenolol Tablets 100mg 18244/0019 Ciprofloxacin Tablets 250mg 18224/0008 Ciprofloxacin Tablets 500mg 18244/0009 Fluoxetine Caps 20mg 18224/0059 Paracetamol Tabs 500mg 18224/0003 Phenoxymethylpenicillin Potassium Tabs 250mg 18224/0049 Ranitidine Tabs 75mg 18224/0028 Ranitidine Tabs 150mg 18224/0006 Ranitidine Tabs 300mg 18224/0007 Details of over one hundred batches are attached to this document as Appendix 1. Please note the Sandoz livery products are listed in line numbers 68, 70 and 72 of Appendix 1. Contd/.. MHRA Distribution: Regional Contacts for NHS Trusts and Provider Units Chief Pharmacists: England, Scotland, Wales, Northern Ireland Prison Health Policy Unit (DH) Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar Special Hospitals Healthcare Commission for distribution to Independent Health Care Establishments Primary Care Trusts (England) Page 1 of 8

Karib Kemi Pharm Ltd, the marketing authorisation holder, are recalling all unexpired stock of the above products due to unsatisfactory shipment conditions during sea transit from their overseas contract manufacturers. All unexpired stock of the listed products and batches should be quarantined and returned for credit. However, care needs to be taken to ensure only those specific batches listed in this drug alert are returned. There are a number of other batches and products which have been transported by air and are not subject to recall action. For any Medical Information enquiries related to this case please call Karib Kemi Pharm Ltd on 07732 166641 or 07732 166891 For enquiries related to stock returns and credit please call Karib Kemi Pharm Ltd on the numbers in the previous paragraph. Further details of the products and liveries involved are attached as Appendix 1. This list has been provided by Karib Kemi Pharm Ltd as all remaining in-date stock which has been shipped by sea. Further information is attached as Questions and Answers in Appendix 2. Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are requested to forward this to relevant clinics, General Practitioners and Community Pharmacists. Yours faithfully Ian Holloway MHRA DMRC Manager Page 2 of 8

Appendix 1 (111 line listing) No. Product Name PL No. Batch Livery Pack Number Size 1 Amoxicillin Caps 250mg 18224/0004 KASC 7002 Karib Kemi 21 2 Amoxicillin Caps 250mg 18224/0004 KASC 7003 Karib Kemi 21 3 Amoxicillin Caps 250mg 18224/0004 KASC 7004 Karib Kemi 21 4 Amoxicillin Caps 250mg 18224/0004 KASC 7005 Karib Kemi 21 5 Amoxicillin Caps 250mg 18224/0004 KASC 7007 Karib Kemi 21 6 Amoxicillin Caps 250mg 18224/0004 KASC 7008 Karib Kemi 21 7 Amoxicillin Caps 250mg 18224/0004 KASC 7009 Karib Kemi 21 8 Amoxicillin Caps 250mg 18224/0004 KASC 7010 Karib Kemi 21 9 Amoxicillin Caps 250mg 18224/0004 KASC 7011 Karib Kemi 21 10 Amoxicillin Caps 250mg 18224/0004 KASC 7012 Karib Kemi 21 11 Amoxicillin Caps 250mg 18224/0004 KASC 7013 Karib Kemi 21 12 Amoxicillin Caps 250mg 18224/0004 KASC 7014 Karib Kemi 21 13 Amoxicillin Caps 250mg 18224/0004 KASC 7015 Karib Kemi 21 14 Amoxicillin Caps 250mg 18224/0004 KASC 7016 Karib Kemi 21 15 Amoxicillin Caps 250mg 18224/0004 KASC 7017 Karib Kemi 21 16 Amoxicillin Caps 250mg 18224/0004 KASC 7018 Karib Kemi 21 17 Amoxicillin Caps 250mg 18224/0004 KASC 7019 Karib Kemi 21 18 Amoxicillin Caps 500mg 18224/0005 KADC 7003 Karib Kemi 21 19 Amoxicillin Caps 500mg 18224/0005 KADC 7004 Karib Kemi 21 20 Amoxicillin Caps 500mg 18224/0005 KADC 7005 Karib Kemi 21 21 Amoxicillin Caps 500mg 18224/0005 KADC 7008 Karib Kemi 21 22 Amoxicillin Caps 500mg 18224/0005 KADC 7009 Karib Kemi 21 23 Amoxicillin Caps 500mg 18224/0005 KADC 7010 Karib Kemi 21 24 Amoxicillin Caps 500mg 18224/0005 KADC 7011 Karib Kemi 21 25 Amoxicillin Caps 500mg 18224/0005 KADC 7012 Karib Kemi 21 26 Amoxicillin Caps 500mg 18224/0005 KADC 7013 Karib Kemi 21 27 Amoxicillin Caps 500mg 18224/0005 KADC 7014 Karib Kemi 21 28 Amoxicillin Caps 500mg 18224/0005 KADC 7015 Karib Kemi 21 29 Amoxicillin Caps 500mg 18224/0005 KADC 7016 Karib Kemi 21 30 Amoxicillin Caps 500mg 18224/0005 KADC 7017 Karib Kemi 21 31 Amoxicillin Caps 500mg 18224/0005 KADC 7018 Karib Kemi 21 32 Amoxicillin Caps 500mg 18224/0005 KADC 7019 Karib Kemi 21 Page 3 of 8

Appendix 1 (111 line listing) No. Product Name PL No. Batch Livery Pack Number Size 33 Amoxicillin Caps 500mg 18224/0005 KADC 7020 Karib Kemi 21 34 Amoxicillin Caps 500mg 18224/0005 KADC 7021 Karib Kemi 21 35 Amoxicillin Caps 500mg 18224/0005 KADC 7022 Karib Kemi 21 36 Amoxicillin Caps 500mg 18224/0005 KADC 7023 Karib Kemi 21 37 Amoxicillin Caps 500mg 18224/0005 KADC 7024 Karib Kemi 21 38 Amoxicillin Caps 500mg 18224/0005 KADC 7025 Karib Kemi 21 39 Amoxicillin Caps 500mg 18224/0005 KADC 7026 Karib Kemi 21 40 Amoxicillin Caps 500mg 18224/0005 KADC 7027 Karib Kemi 21 41 Amoxicillin Caps 500mg 18224/0005 KADC 7028 Karib Kemi 21 42 Amoxicillin Caps 500mg 18224/0005 KADC 7029 Karib Kemi 21 43 Amoxicillin Caps 500mg 18224/0005 KADC 7030 Karib Kemi 21 44 Amoxicillin Caps 500mg 18224/0005 KADC 7031 Karib Kemi 21 45 Amoxicillin Caps 500mg 18224/0005 KADC 7032 Karib Kemi 21 46 Amoxicillin Caps 500mg 18224/0005 KADC 7033 Karib Kemi 21 47 Amoxicillin Caps 500mg 18224/0005 KADC 7034 Karib Kemi 21 48 Amoxicillin Caps 500mg 18224/0005 KADC 7035 Karib Kemi 21 49 Amoxicillin Caps 500mg 18224/0005 KADC 7036 Karib Kemi 21 50 Amoxicillin Caps 500mg 18224/0005 KADC 7037 Karib Kemi 21 51 Amoxicillin Caps 500mg 18224/0005 KADC 7038 Karib Kemi 21 52 Amoxicillin Caps 500mg 18224/0005 KADC 7039 Karib Kemi 21 53 Amoxicillin Caps 500mg 18224/0005 KADC 7040 Karib Kemi 21 54 Amoxicillin Caps 500mg 18224/0005 KADC 7041 Karib Kemi 21 55 Amoxicillin Caps 500mg 18224/0005 KADC 7042 Karib Kemi 21 56 Amoxicillin Caps 500mg 18224/0005 KADC 7043 Karib Kemi 21 57 Amoxicillin Caps 500mg 18224/0005 KADC 7044 Karib Kemi 21 58 Amoxicillin Caps 500mg 18224/0005 KADC 7045 Karib Kemi 21 59 Amoxicillin Caps 500mg 18224/0005 KADC 7046 Karib Kemi 21 60 Amoxicillin Caps 500mg 18224/0005 KADC 7047 Karib Kemi 21 61 Atenolol Tabs 50mg 18224/0018 KA5 701 Karib Kemi 28 62 Atenolol Tabs 50mg 18224/0018 KA5 702 Karib Kemi 28 63 Atenolol Tabs 50mg 18224/0018 KA5 703 Karib Kemi 28 Page 4 of 8

Appendix 1 (111 line listing) No. Product Name PL No. Batch Livery Pack Number Size 64 Atenolol Tabs 100mg 18224/0019 KA1 702 Karib Kemi 28 65 Atenolol Tabs 100mg 18224/0019 KA1 701 Karib Kemi 28 66 Atenolol Tabs 100mg 18224/0019 KA1 703 Karib Kemi 28 67 Ciprofloxacin Tabs 250mg 18224/0008 KF2 601ML Karib Kemi 20 68 Ciprofloxacin Tabs 250mg 18224/0008 SF2 602ML Sandoz 10 69 Ciprofloxacin Tabs 500mg 18224/0009 KF5 601ML Karib Kemi 10 70 Ciprofloxacin Tabs 500mg 18224/0009 SF5 602ML Sandoz 10 71 Ciprofloxacin Tabs 500mg 18224/0009 KF5 701 Karib Kemi 10 72 Ciprofloxacin Tabs 500mg 18224/0009 SF5 702 Sandoz 10 73 Fluoxetine Caps 20mg 18224/0059 DH 10108 Karib Kemi 30 74 Fluoxetine Caps 20mg 18224/0059 DH 10208 Karib Kemi 30 75 Fluoxetine Caps 20mg 18224/0059 DH 10308 Karib Kemi 30 76 Paracetamol Tabs 500mg 18224/0003 DL 10708 Karib Kemi 100 77 Paracetamol Tabs 500mg 18224/0003 DL 10808 Karib Kemi 100 78 Paracetamol Tabs 500mg 18224/0003 DL 10908 Karib Kemi 100 79 Penicillin VK Tabs 250mg 18224/0049 SPT 7004 Karib Kemi 28 80 Penicillin VK Tabs 250mg 18224/0049 SPT 7005 Karib Kemi 28 81 Penicillin VK Tabs 250mg 18224/0049 SPT 7006 Karib Kemi 28 82 Penicillin VK Tabs 250mg 18224/0049 SPT 7007 Karib Kemi 28 83 Penicillin VK Tabs 250mg 18224/0049 SPT 7008 Karib Kemi 28 84 Penicillin VK Tabs 250mg 18224/0049 SPT 7009 Karib Kemi 28 85 Penicillin VK Tabs 250mg 18224/0049 SPT 7010 Karib Kemi 28 86 Penicillin VK Tabs 250mg 18224/0049 SPT 8002 Karib Kemi 28 87 Penicillin VK Tabs 250mg 18224/0049 SPT 8003 Karib Kemi 28 88 Penicillin VK Tabs 250mg 18224/0049 SPT 8004 Karib Kemi 28 89 Penicillin VK Tabs 250mg 18224/0049 SPT 8005 Karib Kemi 28 90 Penicillin VK Tabs 250mg 18224/0049 SPT 8006 Karib Kemi 28 91 Penicillin VK Tabs 250mg 18224/0049 SPT 8007 Karib Kemi 28 92 Ranitidine Tabs 75mg 18224/0028 KR7 701 Karib Kemi 12 93 Ranitidine Tabs 150mg 18224/0006 KR1 704 Karib Kemi 60 94 Ranitidine Tabs 150mg 18224/0006 KR1 705 Karib Kemi 60 95 Ranitidine Tabs 150mg 18224/0006 KR1 706 Karib Kemi 60 Page 5 of 8

Appendix 1 (111 line listing) No. Product Name PL No. Batch Livery Pack Number Size 96 Ranitidine Tabs 150mg 18224/0006 KR1 707 Karib Kemi 60 97 Ranitidine Tabs 150mg 18224/0006 KR1 708 Karib Kemi 60 98 Ranitidine Tabs 150mg 18224/0006 KR1 709 Karib Kemi 60 99 Ranitidine Tabs 150mg 18224/0006 KR1 710 Karib Kemi 60 100 Ranitidine Tabs 150mg 18224/0006 KR1 711 Karib Kemi 60 101 Ranitidine Tabs 150mg 18224/0006 KR1 712 Karib Kemi 60 102 Ranitidine Tabs 150mg 18224/0006 KR1 713 Karib Kemi 60 103 Ranitidine Tabs 150mg 18224/0006 KR1 714 Karib Kemi 60 104 Ranitidine Tabs 150mg 18224/0006 KR1 715 Karib Kemi 60 105 Ranitidine Tabs 150mg 18224/0006 KR1 716 Karib Kemi 60 106 Ranitidine Tabs 150mg 18224/0006 KR1 717 Karib Kemi 60 107 Ranitidine Tabs 150mg 18224/0006 KR1 801 Karib Kemi 60 108 Ranitidine Tabs 150mg 18224/0006 KR1 802 Karib Kemi 60 109 Ranitidine Tabs 300mg 18224/0007 KR3 705 Karib Kemi 30 110 Ranitidine Tabs 300mg 18224/0007 KR3 706 Karib Kemi 30 111 Ranitidine Tabs 300mg 18224/0007 KR3 707 Karib Kemi 30 Appendix 1 Ends Appendix 2 Questions and Answers follows on next page Page 6 of 8

Appendix 2 Questions and Answers Why is a product recall being carried out? These products have been subjected to unsatisfactory conditions during shipment from their overseas manufacturing sites to the UK. Is the temperature monitored during shipment? Yes, but the Qualified Person took no action to review the data, ensure shipment conditions were acceptable or to find a better shipment system. This explains why all remaining in-date stock of these products is being recalled. Why are you not recalling the product to patient level? Products imported from non-eu countries have to be tested on import to the EU. These medicines have been tested on import and passed the required tests. However, testing is a sampling activity which examines a limited proportion of the batch and only reflects the condition at the time of testing. We are adopting a precautionary approach at this stage. If any of the additional testing, mentioned below, indicates a higher risk then we will reconsider this position. Is any more work going on to obtain more information about the risks and potential problems? Yes, laboratory testing is being carried out and should provide more information. This obviously takes time and some problems might only be detected as the product ages. The recall action taken now should minimise risk to the patient. Are all products from this marketing authorisation holder shipped by sea? No. The above listing excludes some recent products which have been shipped by air. Page 7 of 8

Appendix 2 Questions and Answers Are you anticipating any product shortages following these recalls? No. These products are widely used generics with several active suppliers. What should a company do if they think their products may have been subjected to unsatisfactory conditions during shipment? They should call the MHRA Defect Centre on 0207 084 2574 or inform their local medicines inspector. Appendix 2 Ends Page 8 of 8